Treatment satisfaction in Type 2 diabetes patients starting once daily insulin detemir

被引：0

作者：

Smith, I. C. ^{[1
]}

Hansen, J. B. ^{[2
]}

机构：

[1] Novo Nordisk Ltd, Pricing & Hlth Econ Unit, Gatwick, W Sussex, England

[2] Novo Nordisk AS, Bagsvaerd, Denmark

来源：

DIABETIC MEDICINE | 2008年 / 25卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

P245

引用

页数：1

共 50 条

[1] Detemir as a once-daily basal insulin in type 2 diabetes
Nelson, Scott E.
CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS, 2011, 3 : 27 - 37
[2] Insulin detemir for the treatment of obese patients with type 2 diabetes
Hollander, Priscilla A.
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2012, 5 : 11 - 19
[3] Effect of once-daily insulin detemir on oral antidiabetic drug (OAD) use in patients with type 2 diabetes
Vora, J.
Caputo, S.
Damci, T.
Orozco-Beltran, D.
Pan, C.
Svendsen, A. L.
Solje, K. S.
Khunti, K.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2014, 39 (02) : 136 - 143
[4] Study of Once-Daily Levemir (SOLVE™): Weight Changes Associated With the Initiation of Once-Daily Insulin Detemir in Chinese Patients With Type 2 Diabetes
Pan, Changyu
Ji, Qiuhe
Li, Yanbing
DIABETES, 2012, 61 : A612 - A612
[5] Comparison of treatment satisfaction of twice-daily BIAsp 70/30 with once-daily insulin glargine in patients with type 2 diabetes
Brod, M
Lammert, M
Raskin, P
DIABETES, 2005, 54 : A114 - A114
[6] Study of once-daily Levemir (SOLVE™) 3: safety of once-daily insulin detemir in patients with type 2 diabetes treated with oral antidiabetic therapy
Ross, S. A.
Dzida, G.
Ligthelm, R. J.
DIABETOLOGIA, 2011, 54 : S422 - S423
[7] Study of Once-Daily Levemir (SOLVE™): Safety and Efficacy of Once-Daily Insulin Detemir in Routine Clinical Practice in Chinese Patients With Type 2 Diabetes
Pan, Changyu
Lu, Juming
Gao, Zhengnan
DIABETES, 2012, 61 : A616 - A616
[8] Insulin detemir in the treatment of type 1 and type 2 diabetes
Philips, Jean-Christophe
Scheen, Andre
VASCULAR HEALTH AND RISK MANAGEMENT, 2006, 2 (03) : 277 - 283
[9] Treatment Intensification by Stepwise Addition of Prandial Insulin Aspart to Once-Daily Basal Insulin Detemir in Subjects with Type 2 Diabetes: The STEPwise™ Trial
Meneghini, Luigi F.
Hermansen, Kjeld
Mersebach, Henriette
Svendsen, Anne Louise
Kumar, Sudhesh
DIABETES, 2010, 59 : A199 - A199
[10] Once daily dosing with insulin detemir offers advantages compared to NPH insulin in subjects with type 1 diabetes
Russel-Jones, D
Bolinder, J
Simpson, R
Stades, A
Stender, A
Hylleberg, B
Draeger, E
DIABETES, 2003, 52 : A132 - A132

← 1 2 3 4 5 →